大行评级丨伯恩斯坦:上调信诺和CVS健康目标价,评级均升至“跑赢大市”

格隆汇
Yesterday

伯恩斯坦将信诺集团的目标价从307美元上调至358美元,将CVS健康的目标价从91美元上调至94美元,评级均升至“跑赢大市”,认为全面的药品福利管理(PBM)改革已经消除了该板块的主要不确定性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10